CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 27, 2004--POZEN Inc.
(NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the
Company's chairman, president and chief executive officer, will be
speaking to investors at the Deutsche Bank Health Care Conference on
Tuesday, May 4, at 9:00 a.m. Eastern Time in Baltimore. Dr.
Plachetka's presentation will be webcast live and archived on POZEN's
home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has developed what it believes to be one of the
largest and most advanced product pipeline in the field of migraine.
POZEN has development and commercial alliances with GlaxoSmithKline,
Xcel Pharmaceuticals, and Nycomed. The company's common stock is
traded on The Nasdaq Stock Market under the symbol "POZN". For
detailed company information, including copies of this and other press
releases, see POZEN's website: www.pozen.com.
Director, Investor Relations, 919-913-1044
Vice President, Finance and Administration, 919-913-1030